Renya Zeng

No. 324, Jingwu Road
Jinan, 250021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Construction of a novel risk model for esophageal squamous cell carcinoma associated with purinergic signaling pathways and chemoradiotherapy sensitivity genes.

Construction of a novel risk model for esophageal squamous cell carcinoma associated with purinergic signaling pathways and chemoradiotherapy sensitivity genes.

Journal: Frontiers in medicine

Published: November 14, 2025

Targeting NBL1/PI3K/AKT axis to enhance the chemosensitivity and radiosensitivity of esophageal squamous cell carcinoma.

Targeting NBL1/PI3K/AKT axis to enhance the chemosensitivity and radiosensitivity of esophageal squamous cell carcinoma.

Journal: International immunopharmacology

Published: November 12, 2025

Activation of NF-κB signaling pathway in GSDME-low esophageal squamous cell carcinoma cells enhances radioresistance.

Activation of NF-κB signaling pathway in GSDME-low esophageal squamous cell carcinoma cells enhances radioresistance.

Journal: Journal of translational medicine

Published: August 18, 2025

Dual immune checkpoint inhibitor cardonilumab induces immune myocarditis in a patient with cancer-related myocardial metastasis: A case report.

Dual immune checkpoint inhibitor cardonilumab induces immune myocarditis in a patient with cancer-related myocardial metastasis: A case report.

Journal: Oncology letters

Published: May 12, 2025

Prognostic Value of Dynamic Lactate Dehydrogenase Trends in Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma: Retrospective Cohort Study.

Prognostic Value of Dynamic Lactate Dehydrogenase Trends in Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma: Retrospective Cohort Study.

Journal: JMIR cancer

Published: March 06, 2025

GLS2 inhibition synergizes with copper to reprogram TCA cycle for cuproptosis-driven radiosensitization in esophageal cancer.

GLS2 inhibition synergizes with copper to reprogram TCA cycle for cuproptosis-driven radiosensitization in esophageal cancer.

Journal: Experimental hematology & oncology

Published: December 24, 2024

Artificial intelligence in predicting efficacy and toxicity of Immunotherapy: Applications, challenges, and future directions.

Artificial intelligence in predicting efficacy and toxicity of Immunotherapy: Applications, challenges, and future directions.

Journal: Cancer letters

Published: December 02, 2024

Osimertinib plus chemotherapy versus osimertinib for patients with advanced NSCLC with concomitant EGFR and TP53 mutations: a prospective cohort study.

Osimertinib plus chemotherapy versus osimertinib for patients with advanced NSCLC with concomitant EGFR and TP53 mutations: a prospective cohort study.

Journal: Scientific reports

Published: July 05, 2024

Pyroptosis-related long-noncoding RNA signature predicting survival and immunotherapy efficacy in patients with lung squamous cell carcinoma.

Pyroptosis-related long-noncoding RNA signature predicting survival and immunotherapy efficacy in patients with lung squamous cell carcinoma.

Journal: Clinical and experimental medicine

Published: June 04, 2024

MiR-92a-2-5p suppresses esophageal squamous cell carcinoma cell proliferation and invasion by targeting PRDX2.

MiR-92a-2-5p suppresses esophageal squamous cell carcinoma cell proliferation and invasion by targeting PRDX2.

Journal: Experimental cell research

Published: August 15, 2023

Leveraging a disulfidptosis-related signature to predict the prognosis and immunotherapy effectiveness of cutaneous melanoma based on machine learning.

Leveraging a disulfidptosis-related signature to predict the prognosis and immunotherapy effectiveness of cutaneous melanoma based on machine learning.

Journal: Molecular medicine (Cambridge, Mass.)

Published: August 08, 2023

Characteristics of molecular subtypes and cinical outcomes in the immunotherapy Queue of extensive-stage small cell lung cancer patients.

Characteristics of molecular subtypes and cinical outcomes in the immunotherapy Queue of extensive-stage small cell lung cancer patients.

Journal: BMC pulmonary medicine

Published: July 14, 2023

Showing 1-12 of 16

Last Updated: 09/26/2026